May 2008
 
EW WEEK Vol. 13 No. 13
· Pfizer drops trials of NicOx glaucoma drug
· RegenRx awarded patent in Hong Kong
· FDA grants request to expand Neovista’s CABERNET trial
· Bepreve demonstrates efficacy in Phase III trial

[Valid RSS]View this Issue

Would you like to receive EyeWorld Week?

 
Monthly Poll

Do you believe glistenings can become severe enough to affect a patient’s visual acuity?

Yes
No



[ Results | Polls ]

Votes:15|Comments:0
 
Resources

Ophthalmologists

Practice Managers

Consumers


NYU-ASCRS Podcasting


EyeSpaceMD

 
 
Subscription Request Form
Please fill out the following information and click the submit button when finished.
First Name:
Last Name:
Suffix:
Street Address:
City:
State:
Zip:
Country:
Email Address:
Phone Number:
Fax Number:
   
Please check the subspecialty(s) that apply to you.
   
Cataract Surgery Refractive Surgery General Ophthalmology
           
Glaucoma Cornea/External Disease Vitreous/Retina
           
Pediatrics Oculoplastics Pathology
           
All of the above None of the above Other
 
 
 
 


Copyright © 1997-2008 EyeWorld News Service


Visit EyeWorld.mobi for a PDA optimized experience